(Q37022045)
English
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential ef
scientific article published on 25 February 2016
Statements
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty (English)
Pascal J Goldschmidt-Clermont
Samuel Golpanian
Darcy L DiFede
Marietsy V Pujol
Maureen H Lowery
Silvina Levis-Dusseau
Bangon Longsomboon
Ariel Wolf
Aisha Khan
Alan W Heldman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference